PLAY2CONTROL Study

StatusEnrolling by Invitation
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later across 2 updates Aug 2027 → Dec 31, 2027
See other at-risk trials from University of Miami

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrolling by invitation only Show 6 more changesShow less
    • Primary completion pushed from Oct 2027 to Dec 31, 2027
    • Study completion pushed from Oct 2027 to Jun 30, 2028
    • Start date changed from estimate of Oct 2026 to Oct 8, 2026
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Site contact updated
  2. Start date: Aug 2026 to Oct 2026
    • Primary and study completion pushed from Aug 2027 to Oct 2027
    v4
  3. Secondary endpoints: 4 to 5
    • Eligibility criteria expanded, about 4 words
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Miami
244 trials monitored
See 27 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
Obesity
3,888 trials monitored
See 157 trials at risk
Type 2 Diabetes
2,236 trials monitored
See 113 trials at risk
The purpose of this study is to assess the impact of active video gaming participation in otherwise sedentary patients with obesity and Type 2 diabetes mellitus. The study will assess changes in sedentary time, activity level and changes in weight and Hemoglobin A1c, as well as other complications related to obesity that is monitored in clinic.
Trial Details
NCT Number NCT07556679
Lead Sponsor University of Miami
Conditions
(from sponsor)		 Type 2 Diabetes, Obesity & Overweight
Related terms Diabetes Mellitus, Type 2, Obesity, Overweight
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov